Event Date/Time: Oct 21, 2008 End Date/Time: Oct 22, 2008
Report as Spam


Pharma Secure Chain 2008
Lock Down Security against Counterfeit Medicines: Protect your Revenue and Reputation
October 21-22, 2008 • Thistle Marble Arch, London, UK

‘Industry needs to know NOW how to prevent their pharmaceutical market been affected by counterfeit drugs from synthesis to patient.’

“The US based Centre for Medicines in the Public Interest predicts that counterfeit drug sales will reach US$ 75 billion globally in 2010, an increase of more than 90% from 2005.” - WHO
Pharma Secure Chain tackles this issue head on, looking at national and international markets, delving into how the pharmaceutical industry regulators, customs and law enforcers are working together to reduce the risk of counterfeit medicines entering the supply chain.
Join Pharma Secure Chain for two days of discussion and debate as to the best approaches when it comes to strengthening and securing the pharmaceutical supply chain.
Why should you attend?
• Update your knowledge of important industry legislation and regulation
• Maximise available resources to explore new avenues for a tactical approach to counterfeit medicines
• Network with industry experts and peers to learn how to overcome concerns you experience within the supply chain
• Identify specific vulnerabilities that can be addressed to mitigate the risk of counterfeit medicines infiltrating your supply chain
Speakers include:
• Michael Deats, Group Manager, Enforcement and Intelligence, MHRA
• Jean-Marc Bobée, Chairman of the Efpia project for coding and identification of pharmaceuticals in Europe, EFPIA
• Jim Thomson, CEO, the European Alliance for Access to Safe Medicines
• Heinz Kobelt, Secretary General, European Association Euro-Pharmaceutical Companies
• Rachel Hodson-Gibbons, Head of eProcurement, NHS Purchasing and Supply Agency
• Mark Davison, VP Global Pharmaceuticals, SICPA


• Conquer regulatory challenges by drawing lessons from the MHRA anti-counterfeiting strategy to improve security programme.
• Develop a strategic plan to protect your products through exclusive practical knowledge insights: Learn how Johnson & Johnson developed a brand protection plan for a new product launch
• Improve you route to a secure supply chain by assessing the risk of counterfeiting, diversion or tampering of a new product.
• Combat the threat of the internet by injecting safeguards to protect product and patient safety with updates from Novartis
• Develop a best practice layered approach against the threat of counterfeiting, manipulation and diversion by exploring a range of industry strategies and adapting them to your own needs.
• Engage in lively debate on how parallel distribution and a safe supply chain can co-exist and its impact on your company.

Visit www.iqpc.com/uk/securechain for updates on the speaker faculty, details of the conference agenda and more booking discount offers!

Call: +44 (0)207 368 9300
Fax: +44 (0)207 368 9301
Email: enquire@iqpc.co.uk
Visit: www.iqpc.com/uk/securechain


Thistle Marble Arch, London, UK
United Kingdom